Copyright
©The Author(s) 2016.
World J Gastroenterol. Jul 14, 2016; 22(26): 6076-6082
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.6076
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.6076
Table 1 Important abbreviations used in the new preoperative defining system for pancreatic cancer
Symbol | Description | Comments |
Resectability | ||
R | Resectable | |
BR | Borderline resectable | |
LA | Locally advanced | |
Location | ||
H | Pancreatic head | Hu: uncinate process, |
Hn: neck portion | ||
Vascular structure | ||
CA | Celiac axis | |
CHA | Common hepatic artery | |
GDA | Gastroduodenal artery | OGA: origin of gastroduodenal artery |
aRHA | Aberrant right hepatic artery | |
Rt/Lt | Right/left | |
SMA | Superior mesenteric artery | |
SMV | Superior mesenteric vein | |
SMV-SV-PV | Superior mesenteric vein-splenic vein-portal vein |
Table 2 Univariate analysis to predict combined venous vascular resection in treating pancreatic head cancer
Combined venous vascular resection | P value | ||
No | Yes | ||
Resectability | |||
R | 54 | 21 | |
BR | 17 | 17 | |
LA | 2 | 2 | 0.054 |
Radiologic tumor size (cm) | 2.3 ± 0.7 | 2.6 ± 0.8 | 0.044 |
Tumor location | |||
Head | 49 | 24 | |
Uncinate | 22 | 13 | |
Including neck | 2 | 3 | 0.485 |
Radiologic vascular component | |||
No | 52 | 21 | |
Yes | 21 | 19 | 0.002 |
Initial preoperative serum CA19-9 | 846.7 ± 2193.9 | 805.3 ± 1761.9 | 0.919 |
Initial serum total bilirubin | 4.3 ± 5.0 | 4.9 ± 4.6 | 0.528 |
Table 3 Univariate analysis to predict neoadjuvant treatment for pancreatic head cancer
Neoadjuvant treatment | P value | ||
No | Yes | ||
Resectability | |||
R | 52 | 23 | |
BR | 10 | 24 | |
LA | 1 | 3 | < 0.001 |
Radiologic tumor size (cm) | 2.1 ± 5.7 | 2.7 ± 0.9 | < 0.001 |
Tumor location | |||
Head | 46 | 27 | |
Uncinate | 15 | 20 | |
Including neck | 2 | 3 | 0.049 |
Radiologic vascular component | |||
No | 52 | 21 | |
Yes | 11 | 29 | < 0.001 |
Initial preoperative serum CA19-9 | 600.8 ± 1640.6 | 1109.0 ± 2437.1 | 0.189 |
Initial serum total bilirubin | 3.9 ± 4.9 | 5.5 ± 4.9 | 0.087 |
Table 4 Oncologic impact of clinical variables used in the new preoperative defining system
Clinical variables | Exp(B) | 95%CI | P value |
Resectability | 0.019 | ||
BR | 0.222 | 0.073-0.676 | 0.008 |
LA | 0.557 | 0.105-2.955 | 0.492 |
Radiologic tumor size (cm) ≥ 2.4 | 1.696 | 0.993-2.897 | 0.053 |
Tumor location | 0.007 | ||
Hu | 0.952 | 0.557-1.629 | 0.858 |
Hn | 9.461 | 2.634-33.976 | 0.001 |
Vascular relationship with | 0.064 | ||
Venous system | 2.788 | 0.952-8.165 | 0.061 |
Arterial system | 6.208 | 1.562-24.669 | 0.010 |
Both | 2.200 | 0.484-10.006 | 0.307 |
CA19-9 ≥ 825 | 1.709 | 0.777-3.761 | 0.183 |
Total bilirubin ≥ 4.6 | 0.588 | 0.339-1.022 | 0.060 |
Adjusted CA19-9 ≥ 50 | 1.972 | 1.118-3.480 | 0.019 |
- Citation: Yang SJ, Hwang HK, Kang CM, Lee WJ. Preoperative defining system for pancreatic head cancer considering surgical resection. World J Gastroenterol 2016; 22(26): 6076-6082
- URL: https://www.wjgnet.com/1007-9327/full/v22/i26/6076.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i26.6076